This is a StreetInsider.com Premium Only Page

NGM Biopharmaceuticals (NGM) – StreetInsider.com Reports

Aug 3, 2023 05:43 PM NGM Biopharmaceuticals, Inc. (NGM) Tops Q2 EPS by 4c

Jun 8, 2023 06:32 AM NGM Biopharmaceuticals (NGM) Files $300M Mixed Shelf

May 8, 2023 04:06 PM NGM Biopharmaceuticals (NGM) Announces Presentation of Data from Phase 2 Investigator-Sponsored Trial of Aldafermin

May 3, 2023 06:08 AM Citi Starts NGM Biopharmaceuticals (NGM) at Buy

Apr 4, 2023 04:10 PM NGM Biopharmaceuticals (NGM) workforce will be reduced by 75 people

Mar 30, 2023 07:33 AM NGM Biopharmaceuticals (NGM) PT Lowered to $7 at B.Riley

Mar 1, 2023 06:27 AM NGM Biopharmaceuticals, Inc. (NGM) Tops Q4 EPS by 7c

Jan 9, 2023 09:03 AM NGM Biopharmaceuticals (NGM) Outlines Corporate Strategy and Provides Guidance on Key Priorities

Dec 8, 2022 06:33 AM NGM Biopharmaceuticals (NGM) to Present Phase 1 Monotherapy Dose Escalation Trial of NGM707 at ESMO I-O

Nov 4, 2022 07:32 AM NGM Biopharmaceuticals (NGM) PT Raised to $6 at Raymond James

Oct 18, 2022 08:51 AM NGM Biopharmaceuticals (NGM) PT Lowered to $9 at Cowen

Oct 18, 2022 08:22 AM NGM Biopharmaceuticals (NGM) PT Lowered to $8 at B.Riley

Oct 17, 2022 04:34 PM UPDATE: Raymond James Downgrades NGM Biopharmaceuticals (NGM) to Outperform

Oct 17, 2022 04:14 PM Goldman Sachs Downgrades NGM Biopharmaceuticals (NGM) to Neutral

Oct 17, 2022 11:46 AM Jefferies Downgrades NGM Biopharmaceuticals (NGM) to Hold

Oct 17, 2022 11:45 AM Piper Sandler Downgrades NGM Biopharmaceuticals (NGM) to Neutral

Oct 17, 2022 07:39 AM NGM Biopharmaceuticals (NGM) to Resume Trading at 8:00 a.m.

Oct 17, 2022 07:35 AM NGM Biopharmaceuticals (NGM) CATALINA Phase 2 Trial of NGM621 Did Not Meet its Primary Endpoint

Oct 17, 2022 07:26 AM NGM Biopharmaceuticals (NGM) Halted, News Pending

Oct 7, 2022 08:24 AM NGM Biopharmaceuticals (NGM) PT Lowered to $29 at B.Riley

Oct 7, 2022 04:31 AM Implied Volatility Movement

Oct 6, 2022 05:03 AM Implied Volatility Movement

Sep 28, 2022 04:34 AM Implied Volatility Movement

Jul 20, 2022 03:34 AM Jefferies Starts NGM Biopharmaceuticals (NGM) at Buy

Jun 30, 2022 08:04 AM NGM Biopharmaceuticals (NGM) Appoints Siobhan Nolan Mangini as CFO and President

Apr 8, 2022 08:02 AM NGM Biopharmaceuticals (NGM) to Present Late-Breaking Preclinical Research at 2022 AACR Annual Meeting Supporting Development of its Myeloid Reprogramming Portfolio

Feb 7, 2022 08:00 AM NGM Biopharmaceuticals (NGM) Granted FDA Fast Track Designation for NGM621

Jan 7, 2022 09:16 AM NGM Biopharmaceuticals (NGM) PT Raised to $32, Piper Sandler is a Buyer Ahead of CATALINA Readout

Nov 5, 2021 07:30 AM NGM Biopharmaceuticals (NGM) PT Raised to $42 at Raymond James

Sep 16, 2021 01:15 PM NGM Biopharmaceuticals (NGM) PT Raised to $35 at BMO Capital

Sep 16, 2021 08:00 AM NGM Biopharmaceuticals (NGM) Presents Preliminary Findings from Ongoing Phase 1a/1b Dose Escalation Study of NGM120 in Patients with Advanced Solid Tumors at the ESMO

Sep 12, 2021 09:58 PM Raymond James Upgrades NGM Biopharmaceuticals (NGM) to Strong Buy; 'Complement Validated in GA'

Sep 12, 2021 02:41 AM NGM Biopharmaceuticals (NGM) PT Raised to $36 at Goldman Sachs

Sep 7, 2021 07:32 AM NGM Biopharmaceuticals (NGM) PT Raised to $35 at B.Riley

Aug 9, 2021 08:47 AM NGM Biopharmaceuticals (NGM) PT Raised to $32 at Cowen

Aug 6, 2021 09:07 AM NGM Biopharmaceuticals (NGM) PT Raised to $30 at Piper Sandler

May 25, 2021 07:54 AM NGM Biopharmaceuticals (NGM) PT Lowered to $23 at Goldman Sachs

May 24, 2021 05:06 PM NGM Biopharmaceuticals (NGM) PT Lowered to $20 at BMO Capital

May 24, 2021 03:53 PM NGM Biopharmaceuticals (NGM) PT Lowered to $20 at Cowen

May 24, 2021 03:19 PM NGM Biopharmaceuticals (NGM) PT Lowered to $25 at B.Riley, Following Clinical Business Update

May 24, 2021 12:46 PM NGM Biopharmaceuticals (NGM) PT Lowered to $22 at Stifel, Keeps 'Buy'

May 24, 2021 11:28 AM Raymond James Downgrades NGM Biopharmaceuticals (NGM) to Outperform, Following Clinical Business Update

May 24, 2021 09:28 AM Pre-Open Stock Movers 05/24: (SPCE) (SBBP) (ORA) Higher; (NGM) (METX) (XEC) Lower (more...)

May 24, 2021 07:07 AM NGM Biopharmaceuticals (NGM) to Resume Trading at 7:30 a.m.

May 24, 2021 07:00 AM NGM Biopharmaceuticals (NGM) Phase 2b ALPINE 2/3 Study of Aldafermin in NASH Did Not Meet Primary Endpoint

May 24, 2021 06:56 AM NGM Biopharmaceuticals (NGM) Halted, News Pending

Mar 5, 2021 07:26 AM NGM Biopharmaceuticals (NGM) PT Raised to $52 at Raymond James

Mar 2, 2021 08:02 AM NGM Biopharmaceuticals (NGM) Begins Expansion of Ongoing Phase 1b Proof-of-Concept Study of NGM120

Feb 9, 2021 06:12 AM NGM Biopharmaceuticals (NGM) PT Raised to $39 at Goldman Sachs

Jan 6, 2021 06:07 AM NGM Biopharmaceuticals (NGM) Prices 4.63M Share Common Offering at $27/Sh